TY  - JOUR 
AU  - González Juanatey, José Ramón
AU  - Górriz, J.L.
AU  - Ortiz, A.
AU  - Valle, A.
AU  - Soler, M.J.
AU  - Facila, L.
PY  - 2023
SN  - 1365-2060
UR  - http://hdl.handle.net/20.500.11940/21182
AB  - Persons with diabetes and chronic kidney disease (CKD) have a high residual risk of developing cardiovascular (CV) complications despite treatment with renin-angiotensin system blockers and sodium-glucose cotransporter type 2 inhibitors....
LA  - eng
KW  - Humans
KW  - Diabetes Mellitus, Type 2
KW  - Mineralocorticoid Receptor Antagonists
KW  - Receptors, Mineralocorticoid
KW  - Albuminuria
KW  - Diabetic Nephropathies
KW  - Renal Insufficiency, Chronic
KW  - Cardiovascular Diseases
KW  - Kidney
KW  - Fibrosis
KW  - Inflammation
KW  - Glucose
KW  - Sodium
TI  - Cardiorenal benefits of finerenone: protecting kidney and heart
DO  - 10.1080/07853890.2023.2171110
T2  - Annals of Medicine
M2  - 502
KW  - AS Santiago
KW  - CHUS
VL  - 55
ER  -